|
Online CME Activity
Combining Naproxen and Nitric Oxide: A Potential New Approach to Analgesia for Osteoarthritis
|
NOTE: Although this activity is no longer certified for credit, we believe that it contains important information and hope you’ll review, print or email it to a colleague.
Combining Naproxen and Nitric Oxide: A Potential New Approach to Analgesia for Osteoarthritis
0.50 AMA PRA Category 1 Credits™
Learning Objectives
Discuss BP mechanisms with a focus on the chemical biology of nitric oxide and the effects of cyclooxygenase-inhibiting nitric oxide donating (CINOD) drugs in patients with OA and HTN
Accreditation
This educational program is conceived and credited in accordance with ACCME's Essential Areas and Policies, including the 2004 Updated Standards for Commercial Support. Pri-Med faculty hail from a variety of institutions and participate in content development, along with pmiCME's Advisory Boards and its expert review partners, the University of Wisconsin School of Medicine and Public Health and Tufts Health Care Institute. All final decisions about program content are the responsibility of pmiCME.
| Credits |
Type |
Accreditation Statement |
Designation Statement |
| 0.50 |
AMA PRA Category 1 Credits™ |
pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. |
pmiCME designates this educational activity for a maximum of .5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. |
Faculty and Editorial Board
Written By:
William B. White, MD, Professor and Chief, Division of Hypertension & Clinical Pharmacology, Medical Director, Clinical Trials Unit, University of Connecticut School of Medicine, Farmington, Connecticut
Edited By:
Zachary Schwartz, MSc, ELS, pmiCME
Financial Disclosure Statement(s)
Dr White is a consultant to Astellas, Gilead, NicOx, Roche, Savient, and Takeda. He is on the speakers bureau for Boehringer Ingelheim and Forest Pharmaceuticals. He receives grants and/or research support from NIH and Novartis.
The content collaborators at Innovations Consulting Group have no financial relationships to disclose.
Mr Schwartz has no financial relationships to disclose.
Education Partner:
Innovations Consulting Group
Instructions for Obtaining Credit:
Complete this activity. Answer the questions in the attached posttest and evaluation. Click on "claim credit" and follow the instructions to print out the credit certificate.
Computer System Requirements:
Internet Explorer (version 5.5 and above) is the recommended browser for Pri-Med Online eCME activities. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A minimum screen resolution setting of 800 x 600 is recommended. A high-speed Internet connection (DSL, cable modem, or LAN-based) is not required; however, it is recommended for faster download times.
|
|
|